Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries - PubMed

Review

Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries

H C Stary. Basic Res Cardiol. 1994.

Abstract

The composition and structure of adaptive intimal thickening and of atherosclerotic lesions that can develop in human coronary arteries is described. Adaptive thickening occurs in defined locations from birth and represents a self-limited response of the intima to hemodynamic forces present within specific locations. Adaptive thickening does not indicate or presage an atherosclerotic lesion. However, some of the identical intima locations (progression-prone locations) accumulate more lipoprotein in persons exposed to risk factors of atherosclerosis and are first to develop advanced lesions if such lesions develop at all. Atherosclerotic disease can be resolved into eight (I-VIII) lesion types, each characteristic by its cells, matrix, architecture, or other specific features. The numerals I-VI represent the usual sequence in which lesions develop and progress from the initial accumulations of lipoproteins and macrophages to atheroma and fibroatheroma stages which are susceptible to thrombotic deposits and ischemic clinical episodes. The numerals VII and VIII represent morphological variants that may follow or precede Type VI. Types I-IV are the lesions most frequent in the first four decades of life. Type III is a lesion we identified in adolescents and young adults as morphologically intermediate between the small lesions of children (I and II) and the potentially symptom-producing Type IV lesion. Identification of Type III provides evidence that small lesions of children can develop into clinical ones. Because we know the age at which Type III lesions are present in our population, we also known the age when progression to advanced lesions generally begins and when preventive measures should already be in place.

Similar articles

• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. Stary HC, et al. Circulation. 1995 Sep 1;92(5):1355-74. doi: 10.1161/01.cir.92.5.1355. Circulation. 1995. PMID: 7648691 Review.

• The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life.

  Stary HC. Stary HC. Eur Heart J. 1990 Aug;11 Suppl E:3-19. doi: 10.1093/eurheartj/11.suppl_e.3. Eur Heart J. 1990. PMID: 1699762

• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. Stary HC, et al. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1512-31. doi: 10.1161/01.atv.15.9.1512. Arterioscler Thromb Vasc Biol. 1995. PMID: 7670967

• A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. Stary HC, et al. Circulation. 1994 May;89(5):2462-78. doi: 10.1161/01.cir.89.5.2462. Circulation. 1994. PMID: 8181179 Review.

• A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. Stary HC, et al. Arterioscler Thromb. 1994 May;14(5):840-56. doi: 10.1161/01.atv.14.5.840. Arterioscler Thromb. 1994. PMID: 8172861 Review.

Cited by

• 4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.

  Camaré C, Vanucci-Bacqué C, Augé N, Pucelle M, Bernis C, Swiader A, Baltas M, Bedos-Belval F, Salvayre R, Nègre-Salvayre A. Camaré C, et al. Oxid Med Cell Longev. 2017;2017:9172741. doi: 10.1155/2017/9172741. Epub 2017 Apr 5. Oxid Med Cell Longev. 2017. PMID: 28479957 Free PMC article.

• A vibration-based approach to quantifying the dynamic elastance of the superficial arterial wall.

  Wang JJ, Liu SH, Su HM, Chang S, Tseng WK. Wang JJ, et al. Biomed Eng Online. 2016 Apr 16;15:40. doi: 10.1186/s12938-016-0147-4. Biomed Eng Online. 2016. PMID: 27083405 Free PMC article.

• Clinical significance of macrophage phenotypes in cardiovascular disease.

  Medbury HJ, Williams H, Fletcher JP. Medbury HJ, et al. Clin Transl Med. 2014 Nov 21;3(1):63. doi: 10.1186/s40169-014-0042-1. eCollection 2014 Dec. Clin Transl Med. 2014. PMID: 25635207 Free PMC article.

• Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs.

  Lietman CD, Segedy AK, Li B, Fazio S, Atkinson JB, Linton MF, Young PP. Lietman CD, et al. PLoS One. 2017 Sep 8;12(9):e0184620. doi: 10.1371/journal.pone.0184620. eCollection 2017. PLoS One. 2017. PMID: 28886156 Free PMC article.

• Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques - Tampere Vascular Study.

  Sulkava M, Raitoharju E, Levula M, Seppälä I, Lyytikäinen LP, Mennander A, Järvinen O, Zeitlin R, Salenius JP, Illig T, Klopp N, Mononen N, Laaksonen R, Kähönen M, Oksala N, Lehtimäki T. Sulkava M, et al. Sci Rep. 2017 Jan 27;7:41483. doi: 10.1038/srep41483. Sci Rep. 2017. PMID: 28128285 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information